| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.2 | 0.0003 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.092 | 0.2 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.074 | 0.2 |